Xuanwei Zeng
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Pathogenic Ifit1+ neutrophils driven by IRF7 promote liver injury and represent a therapeutic target in acute liver failure.
Journal: Hepatology (Baltimore, Md.)
Published: October 28, 2025
Exogenous/endogenous stimuli-responsive antitumor prodrugs advance precision chemotherapy.
Journal: Bioorganic & medicinal chemistry
Published: September 24, 2025
The actual performance of large language models in providing liver cirrhosis-related information: A comparative study.
Journal: International journal of medical informatics
Published: December 11, 2024
Advances in intrahepatic and extrahepatic vascular dysregulations in cirrhotic portal hypertension.
Journal: Frontiers in medicine
Published: October 22, 2024
Precision-engineered PROTACs minimize off-tissue effects in cancer therapy.
Journal: Frontiers in molecular biosciences
Published: October 02, 2024
Redox-Inducible Radiomimetic Photosensitizers Selectively Suppress Cancer Cell Proliferation by Damaging DNA through Radical Cation Chemistry.
Journal: Angewandte Chemie (International ed. in English)
Published: July 16, 2024
Dual-responsive probe and DNA interstrand crosslink precursor target the unique redox status of cancer cells.
Journal: Chemical communications (Cambridge, England)
Published: November 24, 2023
Effects of adjuvant huaier granule therapy on survival rate of patients with hepatocellular carcinoma.
Journal: Frontiers in pharmacology
Published: February 10, 2023
Development of a nomogram to predict the risk of hepatocellular carcinoma in patients with hepatitis B-related cirrhosis on antivirals.
Journal: Frontiers in oncology
Published: December 22, 2022
Neutrophil-to-high-density-lipoprotein-cholesterol ratio and mortality among patients with hepatocellular carcinoma.
Journal: Frontiers in nutrition
Published: December 20, 2022
Last Updated: 09/26/2026